The CDC reports that upwards of 120,000 adults age 65 and older are hospitalized every year due to RSV.
The Centers for Disease Control and Prevention is one step closer to recommending the RSV vaccine for adults 65 years and older.
The agency's vaccine advisory committee voted 9-2 this week in favor of recommending the vaccine for seniors. The CDC director will now review the recommendation before deciding that the product can be widely administered. RSV typically peaks in the winter months. In healthy individuals, the virus usually presents as a mild cold, which can take a week or two to recover from. However, the CDC reports that upwards of 120,000 adults 65 and older are hospitalized every year due to the respiratory virus, and between 6,000 and 10,000 die. Health officials say older adults with weakened immune systems and chronic heart or lung disease are more likely to have severe outcomes.
Health officials said people who received the vaccine lowered their risk of developing severe disease by 94%. RSV is also a major health concern for babies and young children. The CDC notes that 80,000 children under the age of 5 are hospitalized with RSV every year. There is still no approved vaccine to prevent the illness in children. Trending stories at Scrippsnews.com
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
CDC advisory panel backs use of GSK and Pfizer RSV vaccines in adults 60 and olderThe CDC panel's recommendation moves the U.S. closer to making the respiratory syncytial virus shots from Pfizer and GSK available to seniors.
Read more »
US CDC advisers recommend older adults may receive Pfizer, GSK shots for RSVA panel of advisers to the U.S. Centers for Disease Control and Prevention (CDC) on Wednesday recommended that new vaccines from Pfizer and GSK to prevent severe respiratory syncytial virus (RSV) infections be available to older adults in the U.S. but stopped short of saying all of them should get the shots.
Read more »
CDC vaccine advisers’ vote sets stage for first RSV shot for older adults this fall | CNNAdults 60 and older will be eligible to get a shot that could protect them from respiratory syncytial virus, or RSV, this fall if the US Centers for Disease Control and Prevention follows the advice of its independent vaccine advisory committee.
Read more »
Pfizer, GSK RSV shots for older adults may prevent thousands of hospitalizations, CDC analysis saysThe CDC analysis suggests the shots will reduce the burden of RSV on hospitals in the fall.
Read more »
CDC panel recommends RSV vaccines for adults ages 65 and upThe committee's green light is a key step in making the shots available to the public. Next, the CDC director must recommend the vaccines.
Read more »
CDC Panel Stops Short of Blanket Recommendation for RSV VaxThe Advisory Committee on Immunization Practices stopped short of recommending the vaccines for everyone age 65 and above.
Read more »